Predictive Oncology Inc. [NASDAQ: POAI] closed the trading session at $0.76 on 12/09/20. The day’s price range saw the stock hit a low of $0.6523, while the highest price level was $0.8489. The company report on December 9, 2020 that Predictive Oncology Sends Letter to Shareholders Regarding Special Meeting to be Reconvened on December 30, 2020.
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, sent a letter to shareholders regarding its virtual Special Meeting of Stockholders, original scheduled for December 1, 2020, which will be reconvened December 30, 2020 at 3 p.m. CST.
The Board of Directors and management of Predictive Oncology urge all shareholders to vote “FOR” the proposals being considered at the Special Meeting, primarily because the reincorporation in Nevada will eliminate our obligation to pay the injurious annual Delaware franchise tax, which is currently equal to approximately $170,000 per year. The company can save approximately $158,000 annually in state taxes by reincorporating in Nevada.
The stocks have a year to date performance of -70.98 percent and weekly performance of 2.34 percent. The stock has been moved at -55.45 percent over the last six months. The stock has performed 14.48 percent around the most recent 30 days and changed -12.95 percent over the most recent 3-months.
If compared to the average trading volume of 1.05M shares, POAI reached to a volume of 4146564 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Predictive Oncology Inc. [POAI]:
The Average True Range (ATR) for Predictive Oncology Inc. is set at 0.06, with the Price to Sales ratio for POAI stock in the period of the last 12 months amounting to 9.94. The Price to Book ratio for the last quarter was 0.93, with the Price to Cash per share for the same quarter was set at 0.15.
POAI stock trade performance evaluation
Predictive Oncology Inc. [POAI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.34. With this latest performance, POAI shares gained by 14.48% in over the last four-week period, additionally sinking by -55.45% over the last 6 months – not to mention a drop of -74.65% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for POAI stock in for the last two-week period is set at 55.72, with the RSI for the last a single of trading hit 59.31, and the three-weeks RSI is set at 51.07 for Predictive Oncology Inc. [POAI]. The present Moving Average for the last 50 days of trading for this stock 0.7386, while it was recorded at 0.7294 for the last single week of trading, and 1.3000 for the last 200 days.
Predictive Oncology Inc. [POAI]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Predictive Oncology Inc. [POAI] shares currently have an operating margin of -975.83 and a Gross Margin at +12.39. Predictive Oncology Inc.’s Net Margin is presently recorded at -1373.71.
Return on Total Capital for POAI is now -149.36, given the latest momentum, and Return on Invested Capital for the company is -335.62. Return on Equity for this stock declined to -343.66, with Return on Assets sitting at -148.68. When it comes to the capital structure of this company, Predictive Oncology Inc. [POAI] has a Total Debt to Total Equity ratio set at 49.20. Additionally, POAI Total Debt to Total Capital is recorded at 32.97, with Total Debt to Total Assets ending up at 24.69. Long-Term Debt to Equity for the company is recorded at 2.41, with the Long-Term Debt to Total Capital now at 1.61.
Reflecting on the efficiency of the workforce at the company, Predictive Oncology Inc. [POAI] managed to generate an average of -$605,961 per employee. Receivables Turnover for the company is 2.75 with a Total Asset Turnover recorded at a value of 0.11.Predictive Oncology Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.30.
Predictive Oncology Inc. [POAI]: Insider Ownership positions
There are presently around $0 million, or 2.20% of POAI stock, in the hands of institutional investors. The top three institutional holders of POAI stocks are: VANGUARD GROUP INC with ownership of 278,567, which is approximately 708.589% of the company’s market cap and around 9.30% of the total institutional ownership; CITADEL ADVISORS LLC, holding 31,388 shares of the stock with an approximate value of $24000.0 in POAI stocks shares; and VIRTU FINANCIAL LLC, currently with $17000.0 in POAI stock with ownership of nearly New of the company’s market capitalization.
6 institutional holders increased their position in Predictive Oncology Inc. [NASDAQ:POAI] by around 284,916 shares. Additionally, 10 investors decreased positions by around 967,392 shares, while 3 investors held positions by with 891,617 shares. The mentioned changes placed institutional holdings at 360,691 shares, according to the latest SEC report filing. POAI stock had 2 new institutional investments in for a total of 23,993 shares, while 8 institutional investors sold positions of 964,107 shares during the same period.